TY  - GEN
AU  - Ramsey,L B
AU  - Johnson,S G
AU  - Caudle,K E
AU  - Haidar,C E
AU  - Voora,D
AU  - Wilke,R A
AU  - Maxwell,W D
AU  - McLeod,H L
AU  - Krauss,R M
AU  - Roden,D M
AU  - Feng,Q
AU  - Cooper-DeHoff,R M
AU  - Gong,L
AU  - Klein,T E
AU  - Wadelius,M
AU  - Niemi,M
TI  - The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update
SN  - 1532-6535
PY  - 2014///1124
KW  - Drug Interactions
KW  - Genotype
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - adverse effects
KW  - Liver-Specific Organic Anion Transporter 1
KW  - Muscular Diseases
KW  - chemically induced
KW  - Organic Anion Transporters
KW  - genetics
KW  - Pharmacogenetics
KW  - Polymorphism, Genetic
KW  - Simvastatin
N1  - Publication Type: Journal Article; Practice Guideline; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1038/clpt.2014.125
ER  -